WHC is still in active development. Read this to understand our approach.
depiction of YSGASDXSLKIKOD-UHFFFAOYSA-N.svg
isomerdesign

Remacemide

Check on isomerdesign

drugmap

Remacemide

Check on drugmap

wiki

Remacemide

Check on wiki

Data

InChI: InChI=1S/C17H20N2O/c1-17(19-16(20)13-18,15-10-6-3-7-11-15)12-14-8-4-2-5-9-14/h2-11H,12-13,18H2,1H3,(H,19,20)

Synonyms: FPL 12924AA, FPL 14145,Remacemida, PR 1032-644, FPL 14144,PR 934-423, 2-amino-N-(1-methyl-1,2-diphenylethyl)acetamide, PR-934-423, Remacemida [INN-Spanish], Remacemidum, (+)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide, Remacemide [INN], (+-)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide, Remacemidum [INN-Latin], 2-amino-N-(1,2-diphenylpropan-2-yl)acetamide, PR1032-646, PR 934-423, (-)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide, FPL-12944AA, Remacemide monohydrochloride, (+-)-isomer,Remacemide, FPL 12924

Estimated data

Solubility: -2.523 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 57.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.